CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 159 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $158,000 | -53.9% | 13,054 | -46.3% | 0.00% | -71.4% |
Q3 2019 | $343,000 | +98.3% | 24,300 | +88.3% | 0.01% | +40.0% |
Q4 2018 | $173,000 | -70.5% | 12,907 | -63.7% | 0.01% | -44.4% |
Q1 2018 | $586,000 | -51.4% | 35,605 | -43.0% | 0.01% | -47.1% |
Q3 2017 | $1,205,000 | +52.0% | 62,439 | -7.1% | 0.02% | +88.9% |
Q2 2017 | $793,000 | +627.5% | 67,223 | +190.0% | 0.01% | +350.0% |
Q1 2016 | $109,000 | +87.9% | 23,183 | +52.3% | 0.00% | +100.0% |
Q3 2015 | $58,000 | – | 15,225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
S&T BANK/PA | 334,252 | $9,107 | 1.76% |
Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |